An interaction between thymus or thoracic duct cells and antibody-forming cell precursors has been implicated in the response of mice to sheep erythrocytes (1). The possibility was raised that the thymus contributes cells to the circulating pool of lymphocytes which recognize antigen (ARC) and which influence the differentiation of antibody-forming cell precursors (AFCP) to hemolysin-forming cells. The experimental system employing reconstituted neonatally thymectomized mice failed to detect the existence of AFCP in inoculated lymphoid cell suspensions.
were made at autopsy and mice with such remnants were discarded from the experiments. Thoracic duct cannulation was performed as described in the previous paper (1) .
lrradiagon.--Intact or adult thymectomized mice were exposed to total-body irradiation in a Perspex box. In the case of thymectomized mice, the irradiation was performed i-3 wk after thymectomy. The dose given was 800 fads to mid-point with maximum back scatter conditions and the machine operated under conditions given in the previous paper (1) . The focal skin distance was 50 cm and the absorbed dose rate was 170 rads per minute. When thymectomized irradiated mice were to be protected with bone marrow, they received an intravenous injection of 2-5 million cells in 0.1-O.2 ml Dulbecco's phosphate-buffered saline 1-3 hr postirradlation. All irradiated mice were given oxytetracycline 1 (100 mg per liter) or penicillin 2 (600,000 units per liter) in the drinking water.
Assays for Hemolysin Plaffue--Forming Cells and Hemolytic Foci.--Hemoly'An plaque-
forming ceils were assayed according to the technique of Jeme et al. (4) . The hemolytic focus assay used in the present experiments was a modification of the techniques described by Kennedy et al. (5) and Playfair et al. (6) . The spleens were not frozen but serially sectioned into 250-/z segments by means of a tissue chopper 8 and sequentially transferred with forceps to an agar plate. These plates were then heated to 37°C and double the quantity of the top, soft agar layer as used in the Jerue assay, was poured over the segments. This layer contained 3.8 ml of 1.4% agar in double strength Eagle's medium, 2 mg dextran, and 0.2 ml of 20% sheep erythrocytes. After incubation for 1-2 hr, 1:10 guinea pig serum was added and the plates incubated for a further hour. The serum was then removed and the plates cooled to 4°C. The red cells were stained with benzidine 4 for 1-2 rain to increase the contrast between the areas of hemolysis which had developed around the segments and the intact red cells. Immediately after staining, the hemolytic areas were counted with the aid of a dissecting microscope.
Preparation of Anti-H2 Sera and Invubation of Plaque-Forming Cells.--The methods for
preparing specific anti-H2 sera and for incubating plaque-forming cells were given in the preceding paper (1) .
Statistical Analysis.--The standard errors of the means were calculated and P values determined by Student's t test.
RESULTS

Effect of Syngeneic Thymus, Thoracic Duct, or Bone Marrow Cells in Irradiated Hosts.--lO million CBA thoracic duct cells, thymus cells, or bone marrow
cells were injected together with l0 s SRBC 5 into groups of syngeneic recipients that had been exposed to 800 rads total-body irradiation. The number of PFC per spleen was determined 7 days later. As seen in Table I, 10 million  thoracic duct cells produced on the average 1270 PFC whereas I0 million During investigations of the hemolytic focus-producing capacity of thoracic duct and spleen cell inocula (2) it was noted that the foci produced by thoracic duct cells involved only one or two consecutive segments of the sliced spleens. With spleen cell inocula, hemopoietic regeneration occurred in the irradiated spleens and individual hemolytic loci often extended over three or four seg- ments. To investigate whatever effect hemopoietic regeneration might have on the size of hemolytic foci produced by thoracic duct cells, bone marrow cells were injected simultaneously. In Table H , the results of two experiments using (CBA X C57BL)F1 mice as both donors and recipients, are shown. A mixed inoculum of one million thoracic duct cells and 10 million bone marrow cells did not increase the number of hemolytic loci per spleen over that produced by one million thoracic duct cells alone but greatly increased the number of PFC per spleen.
A time course study of the production of hemolytic loci and PFC per spleen was performed in heavily irradiated CBA mice injected with SRBC and one million CBA thoracic duct cells, 10 million CBA bone marrow ceils or a mixed inoculum of both cell types. 4-9 days after irradiation and cell inoculation, half the number of spleens were assayed for their content of PFC and the other half were serially sectioned to determine the number of hemolytic foci. The results are shown in Figs. I and 2. The majority of heavily irradiated CBA mice of our colony had died by 9 days unless they were given hemopoietic cells. Hence adequate data was not available at 9 days in the case of irradiated mice injected with SRBC and thoracic duct cells alone. At day 8, one million thoracic duct cells produced on the average about 100 PFC and five hemolytic loci per spleen. Addition of bone marrow cells to the inoculum of thoracic duct cells significantly increased the number of PFC per spleen to about 900 (P < 0.01) but did not increase the number of hemolytic foci. As the loci presumably represent discrete dusters of PFC, it can be calculated that, at the peak of the response, the foci resulting from inoculation of thoracic duct cells contain about 20 PFC. The addition of bone marrow cells increased this number to (Fig. 1) . The number of hemolytic loci in bone marrow-injected mice however never increased significantly above the background number of one hemolytic focus per spleen obtained in irradiated mice injected with either SRBC only or lymphoid cells only. These results indicate that while irradiated mice given SRBC and thoracic duct cells alone can produce PFC, this response is greatly increased by the simultaneous injection of bone marrow cells. When thymus cells were used instead of thoracic duct cells, it was evident that even 50 million thymus cells failed to achieve the same effect as one million thoracic duct cells in irradiated mice injected with SRBC and bone marrow (Table III) . Therefore thoracic duct cells were far superior to thymus cells in this system in contrast to what was observed in neonataUy thymectomized mice (1) . This finding prompted the following studies in adult thymectomized irradiated mice injected with bone marrow. The magnitude of twice the standard errors is shown by the vertical bars. Each point at 4, 5, and 9 days represents the mean of determinations made on 2-5 mice and at 6, 7, and 8 days on 6-13 mice.
Effect of Syngeneic Thymus or Thoracic Duct Cells in Thymectomiud Irradi
wk after irradiation and marrow protection. The number of PFC per spleen was determined 2, 4, 5, 7, and 10 days thereafter. From Fig. 3 it can be seen that while mice given thoracic duct cells produced 72,000 PFC, mice receiving the same number of thymus cells could produce only about 6000 PFC at the
,' -. height of the response. Mice injected with SRBC only gave less than 300 PFC. In the case of thoracic duct ceil recipients, the number of PFC increased 12-fold between days 4 and 5. When the data for 10 million thoracic duct cells are compared in Table I and Fig. 3 , it is evident that far more PFC were produced in the bone marrow-protected thymectomized irradiated hosts than in the irradiated hosts not given bone marrow.
It is apparent, therefore, that thymus cells are not as effective as thoracic duct ceils in thymectomized irradiated bone marrow-protected hosts in contrast to the situation (1) in neonatally thymectomized mice. One notable difference between the two hosts was the size of their spleens. Thus, seven mice which had been thymectomized at 6 wk, irradiated and injected with bone marrow cells had an average of 8l -4-7.0 million nucleated spleen cells 2 wk after irradiation, which is significantly less than the average number of 148 million cells in the spleens of neonatally thymectomized mice (1) . The possibility that this accounts for the different results will be discussed later.
Effect of Allogeneic Thymus, Thoracic Duct, and Bone Marrow Cells in Irradiated Hosts.--In order to identify, by means of anti-H2 sera, the identity of PFC produced in irradiated hosts in response to SRBC and thymus, thoracic duct and bone marrow cells, ailogeneic combinations must be used. Accordingly, (CBA X C57BL)Fx thoracic duct cells were injected together with SRBC and CBA bone marrow into heavily irradiated CBA mice. The results of two representative experiments are shown in Table IV . When a mixed inoculum of Fx thoracic duct cells, CBA bone marrow cells, and SRBC was given on the day of irradiation, 800 PFC appeared in the spleens 7 days later. This was only slightly greater than the sum of the mean number of PFC produced in the spleens of mice given either SRBC alone, SRBC and thoracic Table IV , giving thoracic duct cells and SRBC 2 days after bone marrow did not obviously augment the PFC response. Increasing this interval still further was not attempted in these irradiated hosts since it is well known that immunological recovery takes place in irradiated mice given bone marrow. If adult mice are thymectomized prior to irradiation and bone marrow protection, however, the recovery of immunological capacity is impaired (8) . This type of host was therefore chosen to deter- Identity of the Hemolysin Plaque-Forming Cells.--When spleen cell suspensions containing PFC were incubated with specific isoantisera the number of detectable PFC was reduced by 80--100 %. Nonspeeitic isoantisera or normal mouse sera reduced the number to an insignificant extent (1).
Spleen cells from irradiated CBA mice given Fx thoracic duct cells and SRBC on the day of irradiation were incubated with normal CBA or C57BL serum, Table V . Anti-CBA serum reduced the number of P F C b y 85-93 % and anti-C57BL serum reduced the number b y 85-95 %. I t is thus apparent that the P F C produced in these hosts were derived from the inoculated cells.
C E L L T O C E L L I N T E R A C T I O N IN TM'~[UNE R E S P O N S E . II
The number of PFC produced following an inoculation of F1 thoracic duct cells and SRBC was far greater in adult thymectomized irradiated CBA mice injected with CBA bone marrow than in irradiated mice not receiving bone marrow (cf. Tables V and VI). In Table VI * F1 thoracic duct cells were inoculated wk postirradiation and marrow protection. Number in brackets refers to per cent reduction. § Spleens assayed 7 days after thoracic duct cells were inoculated; all others were assayed 5 days after inoculation.
with isoantisera, aliquots of spleen cells from thymectomized irradiated recipients of Fx thoracic duct cells and CBA bone marrow. Anti-CBA serum caused a reduction in the number of PFC of 95-97 % and anti-C57BL resulted in losses of up to 5 %. The majority of PFC produced in these hosts was therefore derived not from inoculated Fx thoracic duct cells but from CBA cells.
DISCUSSION
Cells capable of producing hemolytic foci in the spleens of heavily irradiated mice, above the background number, were detected in thoracic duct lympho-cyte suspensions but not in bone marrow. In irradiated recipients of thoracic duct cells and SRBC, the addition of syngeneic bone marrow did not increase the number of hemolytic foci but increased the number of PFC per spleen to a far greater extent than could be accounted for by summating the activities of either cell population alone. These results can be interpreted in at least two ways. (a) By allowing hemopoietic regeneration and possibly creating a favorable environment in the spleen, bone marrow promotes the differentiation and multiplication of PFC precursors present in thoracic duct lymph. Such PFC precursors were described as antigen-sensitive ceils by Kennedy et al. (5) who considered that the PFC clustered within an area detectable by the hemolytic focus assay technique, were the direct descendants of an antigen-sensitive cell that had lodged in the spleen at the site where the focus arose. As bone marrow did not produce foci, these investigators concluded that it lacked antigen sensitive cells or PFC precursors according to their definition. (b) The second possibility is that bone marrow does provide PFC precursors (the AFCP in our terminology) the differentiation of which can be induced only by the associated presence of some type of cell, presumably derived originally from the thymus and present in thoracic duct lymph (the ARC in our terminology). Clearly, in order to distinguish between these two possibilities, one must identify the source of PFC in irradiated mice receiving bone marrow and thoracic duct or thymus lymphocytes.
In the experiments of Davies et al. (9) (10) (11) , thymectomized irradiated mice were protected with bone marrow and thymus from donors which were slightly different immunogenetically. When the spleens from these thymus-grafted mice were transferred soon after challenge with SRBC, into irradiated recipients presensitized against either the thymus-donor or the marrow-donor, those capable of rejecting cells of thymus donor-type were able to produce antibody in response to SRBC. By contrast, those immunized against marrow donor-type cells produced much less antibody. These transfer experiments were, however, performed 30 days after irradiation and thymus grafting. It is known that, at that time, the lymphoid cell population of the graft has been replaced entirely by cells derived from the bone marrow (12) . Thus hemolysins detected in irradiated mice, presensitized against thymus donor-type cells, may have been produced by bone marrow-derived cells which had repopulated, and migrated from, the thymus graft. Hence the cells producing antibody could have the immunogenetic characteristic of the marrow donor and yet be thymus derived. Thus, "it may be that thymus-derived cells can produce antibody, but only in the presence of cells of bone marrow origin. Equally, cells of bone marrow origin.., may be the cells whose immunological potential is enhanced by association with cells of thymic origin. These are not problems which the present analysis can resolve" (11) .
In the present study, no attempt was made to determine, with anti-H2 sera, the identity of the PFC produced in the spleens of irradiated recipients of a mix~A inoculum of F1 thoracic duct lymphocytes, CBA bone marrow cells, and SRBC, because no synergistic effect was observed in this experimental system. This contrasts with the results obtained in the syngeneic situation but is in general agreement with a previous report indicating that allogeneic thymus and bone marrow cells do not interact in irradiated hosts (13) . Since it appears that a synergistic effect can be obtained only in syngeneic systems, methods other than those using anti-H2 sera must be devised to determine the source of the PFC. The only technique available so far is the detection of a particular chromosome marker in individual antibody-formlng cells (14) . This has been applied to PFC obtained from the spleens of heavily irradiated mice injected simultaneously after irradiation with CBA/T6T6 bone marrow cells, CBA thoracic duct cells, and SRBC and the results will be given in the following paper (15) . ~ The reason for the failure of an interaction to take place between allogeneic lymphocytes and bone marrow cells immediately following transfer to irradiated hosts, is unknown but it may be that the phenomenon of allogeneic inhibition (16) operates. If this is so, however, it no longer operates once differentiation of some bone marrow stem cell has taken place, since an excellent synergistic effect was obtained in thymectom~zed irradiated mice receiving F1 thoracic duct cells and SRBC 2 wk after an injection of CBA bone marrow. In this system, therefore, techniques using anti-H2 sera were used to determine the identity of the PFC produced. The results indicate that the bone marrow must be a source of AFCP since the PFC were CBA-type and not F1-type. This conclusion is corroborated by the results obtained in the following study in which chromosome marker techniques were used (15) . It seems therefore that bone marrow provides AFCP, but not cells capable of initi~ing the production of hemolytic loci, so that it must lack ARC. The hemolytic focus assay is thus a measure, not of the number of PFC precursors in a given population, but of the number of ARC which settle in the irradiated spleens.
Irradiated recipients of thymus cells and SRBC will produce neither hemolytic loci nor PFC in their spleens (5, (17) (18) (19) , When bone marrow is added, however, both hemolytic loci and an increase in the number of PFC per spleens can be detected (17) (18) (19) . One of the differences between the population of cells from thymus and thoracic duct lymph, which could not have been demonstrated in the experimental system used in the previous study (1) , is that PFC can be derived directly from some thoracic duct lymphocytes, but not from thymus cells. The evidence for this is that PFC were produced in the spleens of heavily irradiated recipients of syngeneic thoracic duct cells but not of thymus cells, and that the PFC in the spleens of irradiated CBA mice injected with F1 thoracic duct cells were F1 type. All the evidence obtained in this and the previous study therefore suggests that the thymus contains only ARC, the bone marrow only AFCP, but the thoracic duct lymph contains both ARC and AFCP. Preliminary studies using density gradient centrifugation techniques indicate that the two cell types in thoracic duct lymph may indeed be separated.
It is evident from a lot of experimental data that the immunological activity of thymus cells is inferior to that of spleen or lymph node cells (20) . For instance, mouse thymus cells injected with rat erythrocytes into preirradiated mice enable their hosts to produce much less antibody than a similar number of spleen cells (21) . Furthermore, in order to prevent the protective action of allogeneic bone marrow in irradiated mice two to four times as many syngeneic thymus lymphocytes as syngeneic lymph node cells were required (22, 23) . In the present experiments, a comparison was made between the peak PFC response of irradiated recipients of thymus and bone marrow on the one hand, and of thoracic duct cells and bone marrow on the other. Far more thymus than thoracic duct lymphocytes were required to cooperate with a certain number of bone marrow cells in order to produce a given number of PFC. The mean PFC response in irradiated recipients of thymus and bone marrow was greater than that of mice given either cell population alone, but there was a considerable variation between individual mice (Table III) . The synergistic effect in these experiments was much less impressive than that reported by Claman et al. (17) , perhaps because they gave two injections of SRBC to their irradiated recipients whereas only one such injection was given here at the time of cell transfer. Thymus cells were also less effective than thoracic duct ceils in thymectomized irradiated, bone marrow-protected mice. This difference between the two cell types was not evident in neonatally thymectomized recipients (1) . The spleens of these mice were much larger than those of thymectomized irradiated mice. It is possible that the larger spleens trap more thymus cells since these cells preferentially home there rather than to lymph nodes (24, 25) . Thoracic duct cells, however, have a capacity to recirculate and to home to all the lymphoid tissues (26) . These features might account for the different results obtained in neonatally thymectomized and in adult thymectomized irradiated, bone marrow-protected mice. An alternative possibility is that a particular cell type, which is radiosensitive and required for antigen handling in this system, is present in spleen and thoracic duct lymph, but absent from the thymus lymphocyte population. Neonatal thymectomy would presumably not affect this cell type.
As a general conclusion, it may be said that there are ARC in the thymus but in a proportion that is much less than that found in the cell population of thoracic duct lymph, spleen, and lymph nodes. Perhaps ARC are exported out of the thymus as soon as they are formed so that the thymus would contain a greater proportion of "immature" cells. Perhaps emigrating thymus cells must undergo a period of maturation before they can become ARC. Perhaps this maturation entails interaction with antigen (or macrophageoprocessed antigen) to give rise to a clone of cells that are specifically reactive to the particular antigen (? memory cells). Perhaps only these cells are capable of recirculating so that the population of cells in thoracic duct lymph would be richer in ARC than that in the thymus. Whatever the case may be, it seems evident that in the 195 immune response to SRBC, some interaction takes place between thymus-derived ARC and bone marrow-derived AFCP and that this allows the differentiation of the AFCP to PFC. Whether a similar interaction takes place in other antigenic systems is not known but it would seem more likely to occur only in those immune responses which are initiated by cells the development of which is under thymus control.
SUMMARY
The number of discrete hemolytic foci and of hemolysin-formlng cells arising in the spleens of heavily irradiated mice given sheep erythrocytes and either syngeneic thymus or bone marrow was not significantly greater than that detected in controls given antigen alone. Thoracic duct cells injected with sheep erythrocytes signiiicaatiy increased the number of hemolytic loci and 10 million cells gave rise to over 1000 hemolysin-forming cells per spleen. A synergistic effect was observed when syngeneic thoracic duct cells were mixed with syngeneic marrow cells: the number of hemolysin-forming cells produced in this case was far greater than could be accounted for by summating the activities of either cell population given alone. The number of hemolytic foci produced by the mixed population was not however greater than that produced by an equivalent number of thoracic duct cells given without bone marrow. Thymus cells given together with syngeneic bone marrow enabled irradiated mice to produce hemolysin-formlng cells but were much less effective than the same number of thoracic duct cells. Likewise syngeneic thymus cells were not as effective as thoracic duct cells in enabling thymectomized irradiated bone marrow-protected hosts to produce hemolysin-forming cells in response to sheep erythrocytes.
Irradiated recipients of semiallogeneic thoracic duct cells produced hemolysin-forming cells of donor-type as shown by the use of anti-H2 sera. The identity of the hemolysin-forming cells in the spleens of irradiated mice receiving a mixed inoculum of semiallogeneic thoracic duct cells and syngeneic marrow was not determined because no synergistic effect was obtained in these recipients in contrast to the results in the syngeneic situation. Thymectomized irradiated mice protected with bone marrow for a period of 2 wk and injected with semiallogeneic thoracic duct cells together with sheep erythrocytes did however produce a far greater number of hemolysin-forming cells than irradiated mice receiving the same number of thoracic duct cells without bone marrow. Anti-H2 sera revealed that the antibody4orming cells arising in the spleens of these thymectomized irradiated hosts were derived, not from the injected thoracic duct ceils, but from bone marrow.
I t is concluded that thoracic duct lymph contains a mixture of cell types: some axe hemolysin-forming cell precursors and others are antigen-reactive cells which can interact with antigen and initiate the differentiation of hemolysin-formlng cell precursors to antibody-formlng cells. Bone marrow contains only precursors of hemolysin-formlng cells and thymus contains only antigenreactive cells but in a proportion that is far less than in thoracic duct lymph.
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